Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term follow-up of prior growth hormone-treated adults born small for gestational age
NL-OMON47841Recruiting
- Sponsor
- Erasmus MC
- Start
- May 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of somatropin in Short stature in children born small for gestational age (3 arms), sponsored by Erasmus MC. Primary endpoint: Insulin resistance. Started May 2015; status: recruiting.
02
Drugs
somatropin
03
Conditions
Short stature in children born small for gestational age
Beyond the preview
Go deeper on NL-OMON47841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47841.